Evidence map›Paper›PMID 28275054›Full record

ArticleThe Journal of biological chemistry2017

Crystal Morales, Zihai Li

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Investigating Developmental and Epileptic Encephalopathy UsingInternational journal of molecular sciences · 2020
    Review
  4. Article
  5. Characterization of CNPY5 and its family members.Protein science : a publication of the Protein Society · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Crystal MoralesFrom the Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina 29425 and.
Zihai LiFrom the Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina 29425 and zihai@musc.edu.
Medical University of South Carolina · USUConn Health · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
Project 3: Structural Basis for grp94 Drug Development and Chaperone FunctionP01CA186866 · NCI · OHIO STATE UNIVERSITY · PI LI, ZIHAI · 2015 to 2019
$6.7M
Roles and Mechanisms of gp96 in Chaperoning Innate ImmunityR01AI070603 · NIAID · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LI, ZIHAI · 2007 to 2016
$3.8M
NCI NIH HHS P01 CA186866NCI NIH HHS P30 CA138313NIAID NIH HHS R01 AI070603
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCell LineCysteineDNA Mutational AnalysisDrosophila melanogasterDrosophila ProteinsEndoplasmic ReticulumEscherichia coliGreen Fluorescent ProteinsHSP90 Heat-Shock ProteinsMiceMice, KnockoutMolecular ChaperonesMutationProtein BindingProtein MultimerizationCysteineDrosophila Proteinsglycoprotein 93, DrosophilaGreen Fluorescent ProteinsHSP90 Heat-Shock ProteinsMolecular ChaperonesRNA, MessengerToll-Like ReceptorschaperoneDrosophilagp93gp96innate immunityintegrinprotein foldingtoll-like receptor (TLR)toll receptor

Identifiers

PMID28275054
PMCPMC5399114
OpenAlexW2592504006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.